Sensorion Submits Clinical Trial Application for OTOF-GT, it

MONTPELLIER, France, July 19, 2023--Sensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in Europe

Related Keywords

United Kingdom , France , Germany , Paris , France General , Italy , Cruz Tapia , Stuart Isabelle Abdou , Nawal Ouzren , Institut Pasteur , Pierre Louis Germain , Eu Community Register , Communications Europe France , Consilium Strategic Communications , European Medicines Agency , Regulatory Agency , Drug Administration , International Media Relations , Regulatory News , Clinical Trial Application , Drug Product , Orphan Drug Designation , Rare Pediatric Disease Designation , Chief Executive Officer , Chief Medical Officer , Cisplatin Induced Ototoxicity , Cochlear Limited , Sudden Sensorineural Hearing Loss , Del Castillo , Drug Designations , Investor Relations , Louis Germain , Gene Therapy , Congenital Hearing Loss , Hearing Loss , Clinical Trial , Medicines And Healthcare Products Regulatory Agency , Dtof , Tof Gt , Sensorion , Biotechnology Company , Montpellier ,